Autoreactive T Cells Mediate NK Cell Degeneration in Autoimmune Disease
Author(s) -
Ruolan Liu,
Luc Van Kaer,
Antonio La Cava,
Mary Ann Price,
Denise I. Campagnolo,
Mary Collins,
Deborah Young,
Timothy Vollmer,
FuDong Shi
Publication year - 2006
Publication title -
the journal of immunology
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.176.9.5247
Subject(s) - immunology , degeneration (medical) , autoimmune disease , disease , cell , biology , medicine , antibody , pathology , genetics
Emerging evidence indicates that NK cells play an important and complex role in autoimmune disease. Humans with autoimmune diseases often have reduced NK cell numbers and compromised NK cell functions. Mechanisms underlying this NK cell degeneration and its biological significance are not known. In this study we show that, in an experimental model of human autoimmune myasthenia gravis induced by a self-Ag, the acetylcholine receptor, NK cells undergo proliferation during the initiation of autoimmunity, followed by significant degeneration associated with the establishment of the autoreactive T cell response. We show that NK cell degeneration was mediated by IL-21 derived from autoreactive CD4(+) T cells, and that acetylcholine receptor-immunized IL-21R-deficient mice, with competent NK cells, developed exacerbated autoimmunity. Thus, NK cell degeneration may serve as a means evolved by the immune system to control excessive autoimmunity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom